Navigation Links
Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
Date:10/13/2010

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna -- OOSTERHOUT, Netherlands, Oct. 13 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna

   

Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research


Download image

OOSTERHOUT, Netherlands, Oct. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), today announced that it will host Planet xMAP Europe 2010, its annual European multiplexing technology symposium, October 20-21, 2010, at The Hofburg in Vienna, Austria. The event will feature scientific sessions, workshops, discussion groups, exhibitions and networking events with scientists and researchers from around the world who are performing groundbreaking work in clinical diagnostics and life science research using Luminex's xMAP® multiplexing technology platform.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)

"Planet xMAP Europe is an excellent opportunity for scientists to gather and exchange ideas on how xMAP multiplexing technology is revolutionizing their laboratories and research," said Paul C. Ladestein, General Manager European Operations for Luminex. "We look forward to welcoming these leading scientists to our exciting new venue at The Hofburg in Vienna."

Planet xMAP Europe 2010 will feature two days of presentations with six focused session options.

Day One of Planet xMAP Europe 2010, Wednesday, 20 October, will focus on Pathogen Detection, Immunology-Monitoring and HLA-Human Genetics. The morning session will include the following presentations:

- Professor Sabine Bahn, MD, PhD, MRCPsych, of the Cambridge Centre for Neuropsychiatric Research Institute of Biotechnology, University of Cambridge, UK, "Disease Biomarkers in First-onset Schizophrenia"

- Professor Jean Louis Merlin, PharmD, PhD, of Tumor Biology Unit, Nancy University Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France, "Phosphoprotein array for characterization of Human Tyrosine kinase receptors downstream signaling functionality as response predictive marker to targeted therapy in translational oncology research programs"

- Professor Alex van Belkum, Department of Medical Microbiology and Infectious Diseases Erasmus MC, Rotterdam, The Netherlands, "Multi-parameter assessment of the humoral response to colonisation and infection with opportunistic microbial pathogens from the human Nasopharyngeal cavity"

- Professor Jonas Blomberg, Section of Virology, Department of Medical Sciences, Uppsala University, Sweden, "More for less; multiplex broadly targeted nucleic acid and serology analyses from the same clinical sample"

- Tim Dehne, Vice President of Systems Research and Development, Luminex Corporation, "MAGPIX: The Next Dimension in Multiplexing"

The afternoon session will feature three separate tracks focused on Pathogen Detection, Immunology-Monitoring, and Human Genetics.

Day Two of Planet xMAP Europe 2010, Thursday, 21 October, will focus on Protein and Genomic Research, and xTAG RVP Fast.The morning session will include the following presentations:

- Carlo M. Croce, MD, Department of Molecular Virology, Immunology and Medical Genetics The Ohio State University Medical Center, Columbus, Ohio, USA, "Causes and consequences of microRNA Dysregulation in cancer"

- Nicholas Haining, Assistant Professor of Pediatrics, Department of Pediatric Oncology Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, "Gene-expression based high-throughput screening"

- Anna E. Lokshin, PhD, Hillman Cancer Institute, Luminex Core Facility, University of Pittsburgh, USA, "Urine as a source of cancer biomarkers"

The afternoon session will feature a special xTAG RVP Fast Workshop on current and future trends in respiratory viral testing.

For detailed information regarding the Planet xMAP Europe 2010 symposium and agenda, or to register online, please visit http://www.planetxmap.com.

About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at www.luminexcorp.com.Luminex Corporate Contact:Harriss T. CurrieVice President, Finance and Chief Financial Officer512.219.8020Matthew ScaloSr. Director Investor Relations512.219.8020mscalo@luminexcorp.comLuminex Media Contact:Aaron De Lucia512-241-2249aaron.delucia@porternovelli.com
'/>"/>

SOURCE Luminex Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
2. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
3. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
4. Luminex Corporation to Present at UBS Global Life Sciences Conference
5. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
6. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
7. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
8. Arable Corporation Announces New Technology for Clinical Trial Industry
9. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
10. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
11. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Calif. , Mar 29, 2017  Providence ... technology, announced the addition of two industry veterans ... has joined the company to lead Global ... International leadership.  Together, Mr. Lynch and Mr. Scott ... Mr. Lynch joins the company ...
(Date:3/29/2017)... N.J. , March 29, 2017  Glenmark ... results for GSP 301, an investigational fixed-dose combination ... (665 mcg) administered twice-daily as a nasal spray ... rhinitis. These results are from a recently completed ... of GSP 301 combination therapy versus mometasone, olopatadine ...
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care Management ... new PhRMA report on patient out-of-pocket spending: ... and Medicaid Services (CMS), the average amount spent out-of-pocket ... of drug spending in 2016, down from 23% in ... pricing problem, not a coverage problem. Health plans don,t ...
Breaking Medicine Technology:
(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... ... is expanding its educational offerings of corporate finance programs to address the increasingly ... program, will help executives increase their knowledge of sophisticated corporate finance and will ...
(Date:3/30/2017)... ... March 30, 2017 , ... ... Academy of Nutrition and Dietetics (AND), will join nonprofit Seafood Nutrition Partnership (SNP) ... a live webinar designed to help nutrition educators and students inform consumers about ...
(Date:3/29/2017)... ... March 29, 2017 , ... During the last week ... free screening colonoscopies to eligible individuals in the local community. , Colon cancer ... regular screenings can detect colon cancer while it is small, confined and easier to ...
(Date:3/29/2017)... NY (PRWEB) , ... March 29, 2017 , ... ... men’s and women’s professional squash, announced it has enlisted New York City-based sports ... The agency will develop and procure sponsorship opportunities for the Professional Squash Association ...
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC TITLE ... the official title sponsor of the Baltimore Women’s Classic, the largest all women’s 5K ... walk or run the course around the Baltimore Inner Harbor. Mercy has been the ...
Breaking Medicine News(10 mins):